COMBINATION THERAPY WITH ANTI-IL-8 ANTIBODIES AND ANTI-PD-1 ANTIBODIES FOR TREATING CANCER

Provided herein are methods for the clinical treatment of tumors (e.g., advanced solid tumors) in patients having certain levels of serum IL-8 using an anti-IL-8 antibody in combination with an anti-PD-1 antibody.

Saved in:
Bibliographic Details
Main Authors ZHOU, Ming, FELTQUATE, David, DE HENAU, Olivier, FENG, Ye, REILLY, Timothy, Patrick, CHEN, Tian, SURESH, Ramachandran, CARLETON, Michael, HUANG, Shu-Pang, Ben
Format Patent
LanguageEnglish
French
German
Published 18.11.2020
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
TESTING
Online AccessGet full text

Cover

Abstract Provided herein are methods for the clinical treatment of tumors (e.g., advanced solid tumors) in patients having certain levels of serum IL-8 using an anti-IL-8 antibody in combination with an anti-PD-1 antibody.
AbstractList Provided herein are methods for the clinical treatment of tumors (e.g., advanced solid tumors) in patients having certain levels of serum IL-8 using an anti-IL-8 antibody in combination with an anti-PD-1 antibody.
Author DE HENAU, Olivier
ZHOU, Ming
HUANG, Shu-Pang, Ben
REILLY, Timothy, Patrick
CHEN, Tian
CARLETON, Michael
FELTQUATE, David
SURESH, Ramachandran
FENG, Ye
Author_xml – fullname: ZHOU, Ming
– fullname: FELTQUATE, David
– fullname: DE HENAU, Olivier
– fullname: FENG, Ye
– fullname: REILLY, Timothy, Patrick
– fullname: CHEN, Tian
– fullname: SURESH, Ramachandran
– fullname: CARLETON, Michael
– fullname: HUANG, Shu-Pang, Ben
BookMark eNrjYmDJy89L5WSIcvb3dfL0cwzx9PdTCPFwDXIMiFQI9wzxUHD0C_HU9fTRtQCznPxdPF2DgUwXiESAi64hsoSbf5BCSJAr0Bw_dwVnRz9n1yAeBta0xJziVF4ozc2g4OYa4uyhm1qQH59aXJCYnJqXWhLvGmBsbmxuZmnmaGhMhBIA78Myqw
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
Physics
DocumentTitleAlternate KOMBINATIONSTHERAPIE MIT ANTI-IL-8-ANTIKÖRPERN UND ANTI-PD-1-ANTIKÖRPERN ZUR BEHANDLUNG VON KREBS
POLYTHÉRAPIE FAISANT INTERVENIR DES ANTICORPS ANTI-IL-8 ET DES ANTICORPS ANTI-PD-1 POUR LE TRAITEMENT DU CANCER
ExternalDocumentID EP3737696A1
GroupedDBID EVB
ID FETCH-epo_espacenet_EP3737696A13
IEDL.DBID EVB
IngestDate Fri Jul 19 13:09:14 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
German
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_EP3737696A13
Notes Application Number: EP20190703442
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201118&DB=EPODOC&CC=EP&NR=3737696A1
ParticipantIDs epo_espacenet_EP3737696A1
PublicationCentury 2000
PublicationDate 20201118
PublicationDateYYYYMMDD 2020-11-18
PublicationDate_xml – month: 11
  year: 2020
  text: 20201118
  day: 18
PublicationDecade 2020
PublicationYear 2020
RelatedCompanies Bristol-Myers Squibb Company
RelatedCompanies_xml – name: Bristol-Myers Squibb Company
Score 3.306856
Snippet Provided herein are methods for the clinical treatment of tumors (e.g., advanced solid tumors) in patients having certain levels of serum IL-8 using an...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
TESTING
Title COMBINATION THERAPY WITH ANTI-IL-8 ANTIBODIES AND ANTI-PD-1 ANTIBODIES FOR TREATING CANCER
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201118&DB=EPODOC&locale=&CC=EP&NR=3737696A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT4NAEJ409XnTqrG-sgfDjVjKWuDQGFioYCwQglq9NDyTXmhjMf59Z7e09qK3yU4ygUm-_WZg51uA2yLtpcgjVE6LsmlQDB3xmKcGzVQFOSEXap_-wH2hT5P7SQtm61kYoRP6LcQREVEZ4r0W-_Xi9yOWLc5WLu_SGS7NH0bx0Jaa7pizGcLZtoZOGNgBkxhDS_KjoaohkoyBiY3SDq-iucy-82rxoZTFNqOMjmA3xGBVfQytourAAVtfvNaB_XHzv7sDe-KAZrbExQaEyxP4YMHY8lYytiR2ncgM38mbF7vE9GNP9p5lXVhWwGs9NO2VI7RlZduB_R-JIwfj-I-E8UtqolMgIydmroyPO92kZuqEmxdTz6BdzaviHIiRKLRUMkXLdUo1o58kZYmFTVZo_SzvqbQL3T_DXPzju4RDnmM-iqfoV9CuP7-Ka-TkOr0R2fwBl5OH6Q
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT4NAEJ409VFvWjXW5x5Mb8RS1gKHxpSFCtoCIajVS1NeSS-0EYx_39ktrb3obbKTTGCSb78Z2PkW4DaNOhHyCJWiNKsaFF1DPCaRTmNFRk5IhNqn27Nf6NPkflKD-XoWRuiEfgtxRERUjHgvxX69_P2IZYqzlcVdNMelxcMw7JvtqjvmbIZwNo2-5Xumx9qModV2g76iIpL03gAbpR2Vi_PyyunV4EMpy21GGR7Cro_B8vIIamnehAZbX7zWhP1x9b-7CXvigGZc4GIFwuIYPpg3NpyVjC0JbSsY-O_kzQltMnBDR3JGkiYsw-O1HprmyuGbkrztwP6PhIGFcdxHwvglNcEJkKEVMlvCx51uUjO1_M2LKadQzxd5egZEn8k0k2NZTTRKVb07m2UZFjZxqnbjpKPQFrT-DHP-j-8GGnY4Hk1Hjvt8AQc833wsT9YuoV5-fqVXyM9ldC0y-wMb84rW
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=COMBINATION+THERAPY+WITH+ANTI-IL-8+ANTIBODIES+AND+ANTI-PD-1+ANTIBODIES+FOR+TREATING+CANCER&rft.inventor=ZHOU%2C+Ming&rft.inventor=FELTQUATE%2C+David&rft.inventor=DE+HENAU%2C+Olivier&rft.inventor=FENG%2C+Ye&rft.inventor=REILLY%2C+Timothy%2C+Patrick&rft.inventor=CHEN%2C+Tian&rft.inventor=SURESH%2C+Ramachandran&rft.inventor=CARLETON%2C+Michael&rft.inventor=HUANG%2C+Shu-Pang%2C+Ben&rft.date=2020-11-18&rft.externalDBID=A1&rft.externalDocID=EP3737696A1